Extrahepatic manifestations of hepatitis C virus infection. Are they overlooked?;Ekstrahepatiske manifestasjoner ved hepatitt C-infeksjon. Blir de oversett?

Tidsskrift for den Norske Laegeforening

Volumn 121, Issue 4, 2001, Pages 446-449

  Kristiansen, Magnhild Gangsøy ^a   Florholmen, Jon ^b  

^a Medisinsk Avdeling   (Norway)

^b Medisinsk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNE THYROIDITIS; B CELL LYMPHOMA; CRYOGLOBULINEMIA; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; LICHEN PLANUS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; PORPHYRIA CUTANEA TARDA; REVIEW; SIALOADENITIS; SJOEGREN SYNDROME;

AUTOIMMUNE DISEASES; CRYOGLOBULINEMIA; GENOTYPE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; HEPACIVIRUS; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; LICHEN PLANUS; LYMPHOMA, B-CELL; PORPHYRIA CUTANEA TARDA; SIALADENITIS; SJOGREN'S SYNDROME; THYROIDITIS, AUTOIMMUNE;

EID: 0035835681     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Fern C, La Civita L, Fazzi P, Solfanelli S, Lombardini F, Bergliomini E et ai. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. B J Rheumatol 1997; 36: 360-5.
2. Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prummer O, Klatt S et al. HCV and HGV in B-cell non-Hodgkin's lymphoma. J Hepatol 1998; 28: 34-9.
3. Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 2000; 32(suppl 1): 98-112.
4. Lunel F, Musset L. Hepatitis C virus infection and cryoglobulinemia. J Hepatol 1998; 29: 848-55.
5. Luppi M, GraziaFerrari M, Bonaccorsi G, Longo G, Narni F, Barozzi P et al. Hepatitis C virus infection in subject of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351-5.
6. Cassani F, Valentini P, Cataleta M, Manotti P, Francesconi R, Giostra F et al. Ultrasound-detected abdominal lymphadenopathy in chronic hepatitis C: high frequency and relationship with viremia. J Hepatol 1997; 26: 479-83.
7. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-70.
8. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux J-M, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996; 25: 427-32.
9. Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999; 31 (suppl 1): 39-42.
10. Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997; 92: 4-15.
11. Zignego AL, Brechot C. Extrahepatic manifestations of HCV infections: facts and controversies. J Hepatol 1999; 31: 369-76.
12. Lunel F, Cacoub P. Treatment of autoimmune and extrahepatic manifestations of hepatitis C infection. J Hepatol 1999; 31 (suppl 1): 210-6.
13. Gerber MA. Pathobiologic effects of hepatitis C. J Hepatol 1995; 22 (suppl 1): 83-6.
14. Rodriguez-Inigo E, Bartolome J, de Lucas S, Manzarbeitia F, Pardo M, Arocena C et al. Histological damage in chronic hepatitis C is not related to the extent of infection in the liver. Am J Pathol 1999; 154: 1877-81.
15. Johnson Y-NL. Mechanisms of hepatitic toxicity IV. Pathogenetic mechanisms involved in hepatitis C virus-induced liver diseases. Am J Physiol 1998; 275: G1217-G20.
16. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type-2-like T-helper cells in hepatitis C virus infection: implications of hepatitis C virus chronicity. Hepatology 1997; 25: 449-58.
17. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD 30 induction and cytpkine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol 1997; 159: 1012-8.
18. Kuzushita N, Hayashi N, Katayama K, Kanto T, Oshita M, Hagiwara H et al. High level of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C. Scand J Gastroenterol 1997; 32: 169-74.
19. Antonaci S, Schiraldi O. Costimulatory molecules and cytotoxic T cells in chronic hepatitis C: defence mechanisms devoted to host integrity or harmful events favouring liver injury progression. Immunopharmacol Immunotoxicol 1998; 20: 455-72.
20. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J Gen Virol 1993; 74: 2391-9.
21. Fernandez I, Castellano G, Domingo MJ, Fuertes A, Colines F, Canga F et al. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection. Scand J Gastroenterol 1997; 32: 70-6.
22. Bell H, Helium K, Harthug S, Myrvang B, Ritland S, Mæland A et al. Treatment with interferon-alpha 2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-aplha2a. Scand J Gastroenterol 1999; 34: 194-8.
23. Zignego AL, Ferri C, Giannini C, Monti M, LaCivita L, Careccia G et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996; 124: 31-4.
24. Weiner SM, Berg T, Berthold H, Weber S, Peters T, Blum HE et al. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 1998; 29: 375-84.
25. Ferri C, Marzo E, Longombardo G, Lombardini F, LaCivita L, Vanacore R et al. Interferon alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 1993; 81: 1132-6.
26. Meltzer M, Franklin EC, Elias K, McCluskey RY, Cooper N. Cryoglobulinemia: a clinical and laboratory study II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966; 40: 837-56.
27. Hadziyannis SJ. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepatitis 1997; 4: 9-28.
28. Zignego AL, Ferri C, Giannini C, LaCivita L, Careccia G, Longombardo G et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkins lymphoma: evidence for a pathogenetic role. Arch Virol 1997; 142: 545-55.
29. DaRosa G, Gobbo ML, DeRenzo A, Notaro R, Garofalo S, Grimaldi M et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997; 55: 77-82.
30. Vallisa D, Berte R, Rocco A, Civardi G, Giangregorio F, Ferrari B et al. Association between hepatitis C virus and non-Hodgkin's lymphoma and effects of viral infection on histologic subtype and clinical course. Am J Med 1999; 106: 556-60.
31. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-8.
32. Brind AM, Watson JP, Burt A, Kestevan P, Wallis J, Proctor SJ et al. Non-Hodgkin's lymphoma and hepatitis C virus infection. Leuk Lymphoma 1996; 21: 127-30.
33. Mccoll MD, Singer IO, Tait RC, McNeil IRR, Cumming RIC, Hogg RB. The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma - a regional association. Leuk Lymphoma 1997; 26: 127-30.
34. Bódas J, Rodriguez-Espinosa J, Enriguez J, Miralles F, Martinez-Cerezo FJ, Gonzalez P et al. Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 1995; 22: 611-5.
35. Broussolle C, Steineur MP, Bally F, Zoulim F, Trepo C. Hepatitis C viral infection and thyroid diseases. Rev Med Interne 1999; 20: 766-73.
36. Gumber SC, Chopra S. Hepatitis C: multifaceted disease, review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
37. Pereyo NO, Lesher JL, Davis LS. Hepatitis C and its association with lichen planus and porphyria cutanea tarda. J Am Academy Dermatol 1995; 32: 531-2.
38. Daoud MS, Gibson LE, Daoud S, elAzhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clin Proc 1995; 70: 559-64.
39. Nagao Y, Sata M, Itoh K, Tanikawa K, Kameyama T. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996; 26: 495-8.
40. Bellmann B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C. Lancet 1995; 346: 1234.
41. Coll J, Gambus G, Corominas J, Tomas S, Esteban JI, Guardia J. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection. Ann Rheum Dis 1997; 56: 390-2.
42. Cresta P, Musset L, Cacoub P, Frangeul L, Vitour D, Poynard T et al. Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut 1999; 45: 122-8.
43. Durand JM, Cacoub P, Lunel-Fabiani F, Cosserat J, Cretel E, Kaplanski G et al. Ribivirin in hepatitis C related cryoglobulinemia. J Rheumatol 1998; 25: 1115-7.
44. Zuckerman E, Slobodin G, Tamir A, Naschitz JB, Taykounov J Bladir D et al. Treatment of refractory, symptomatic HCV RNA related mixed cryoglobulinemia (MC) with ribavirin and interferon alpha. Abstrakt. Hepatology 1998; 374: A846.